Summit Preview

Executive Briefing: Artificial Intelligence & Machine Learning

Wednesday, April 1, 2020

Experienced leaders. Candid, intimate discussions.

CEOs and select C-suites from health plans, health systems and life science companies are leading in times of increasingly complex technology that holds enormous potential value for health. This invitation-only, intimate gathering is designed to demystify the hype and the challenges of leading through the AI/ML revolution to reduce costs and increase value.

Discussions delve into how different sectors are leveraging AI and ML, business use cases and outcome metrics, culture change and talent management, and assessment of risks and unintended consequences. Candid CEO peer exchanges provide practical lessons and in-depth, actionable insights that drive toward the future of AI-enabled health.

Executive Briefing Agenda

Wednesday, April 1
Emcee: Steve Udvarhelyi, MD, President & CEO, Blue Cross and Blue Shield of Louisiana
8–9 amFederal Government’s Evaluation and Application of AI
Host: Mark McClellan, MD, Director, Duke-Margolis Center for Health Policy & Robert J. Margolis, M.D., Professor of Business, Medicine and Policy

Discussion Leader: Amy Abernethy, MD, Principal Deputy Commissioner, FDA
9–10:15 amBreaking the Hype Cycle: The Realities of AI Use Cases, Challenges and Risks

Discussion Leaders:
Mark Ganz, CEO, Cambia Health; Summit Chair
Faraz Shafiq, Chief Artificial Intelligence Officer, Cambia Health
10:15–10:45 amNetworking Break
10:45 am–12 pmBusiness Use Cases - Progressive AI/ML Initiatives for Operational Efficiencies

Discussion Leaders:
Steve Corwin, MD, CEO, NewYork-Presbyterian
Peter Fleischut, MD, SVP & Chief Transformation Officer, NewYork-Presbyterian
12–2 pmLuncheon with CEO Roundtable Discussions
CEO Roundtables curate interactive discussions among market leaders that share their approaches, action plans and lessons learned with those that are embarking on or advancing AI/ML initiatives.
    – AI-enabled consumer-focused delivery and customer service improvement
    – Utilizing AI to identify members/patients for interventions
    – Utilizing AI to aid in clinical decision support and diagnosis
    – Utilizing AI for therapeutics/treatments
    – Partnership considerations: Investment, ROI and risk assessment
    – Culture change and hiring/talent acquisition and management
    – AI-enabled value-based care and benchmarking
    – AI for market segmentation and product/service customization
    *Tentative roundtable discussions. Final roundtable discussions will be based on participant preferences

Leadership Committee (partial list)

  • Aneesh Chopra, President, NavHealth; Former U.S. Chief Technology Officer
  • Rod Hochman, MD, President & CEO, Providence St. Joseph
  • Steve Klasko, MD, President & CEO, Thomas Jefferson University and Jefferson Health
  • Mark McClellan, MD, Director, Duke-Margolis Center for Health Policy & Robert J. Margolis, M.D., Professor of Business, Medicine and Policy
  • Steve Udvarhelyi, MD, President & CEO, Blue Cross Blue Shield Louisiana


    View Insights

    The Great Beyond: Technology + Humans Deliver Health

    Molly Coye, MD, Executive in Residence, AVIA; Confab Committee, in discussion with Vinod Khosla, Founder, Khosla Ventures